The term vascular cognitive impairment (VCI) was introduced around the start of the new millennium and refers to the contribution of vascular pathology to any severity of cognitive impairment, ranging from subjective cognitive decline and mild cognitive impairment to dementia. Although vascular pathology is common in elderly individuals with cognitive decline, pure vascular dementia (that is, dementia caused solely by vascular pathology) is uncommon. Indeed, most patients with vascular dementia also have other types of pathology, the most common of which is Alzheimer disease (specifically, the diffuse accumulation of amyloid-β plaques and neurofibrillary tangles composed of tau). At present, the main treatment for VCI is prevention by treating vascular diseases and other risk factors for VCI, such as hypertension and diabetes mellitus. Despite the current paucity of disease-modifying pharmacological treatments, we foresee that eventually, we might be able to target specific brain diseases to prevent cognitive decline and dementia.

Vascular cognitive impairment / W.M. van der Flier, I. Skoog, J.A. Schneider, L. Pantoni, V. Mok, C.L.H. Chen, P. Scheltens. - In: NATURE REVIEWS. DISEASE PRIMERS. - ISSN 2056-676X. - 4(2018 Feb 15), pp. 18003.1-18003.16. [10.1038/nrdp.2018.3]

Vascular cognitive impairment

L. Pantoni;
2018

Abstract

The term vascular cognitive impairment (VCI) was introduced around the start of the new millennium and refers to the contribution of vascular pathology to any severity of cognitive impairment, ranging from subjective cognitive decline and mild cognitive impairment to dementia. Although vascular pathology is common in elderly individuals with cognitive decline, pure vascular dementia (that is, dementia caused solely by vascular pathology) is uncommon. Indeed, most patients with vascular dementia also have other types of pathology, the most common of which is Alzheimer disease (specifically, the diffuse accumulation of amyloid-β plaques and neurofibrillary tangles composed of tau). At present, the main treatment for VCI is prevention by treating vascular diseases and other risk factors for VCI, such as hypertension and diabetes mellitus. Despite the current paucity of disease-modifying pharmacological treatments, we foresee that eventually, we might be able to target specific brain diseases to prevent cognitive decline and dementia.
Settore MED/26 - Neurologia
15-feb-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
Nat Rev Dis Primers_VCI_2018.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 4.13 MB
Formato Adobe PDF
4.13 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/551554
Citazioni
  • ???jsp.display-item.citation.pmc??? 168
  • Scopus 258
  • ???jsp.display-item.citation.isi??? 290
social impact